Meritage Portfolio Management raised its position in shares of Exelixis, Inc. (NASDAQ:EXEL – Get Rating) by 164.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 424,235 shares of the biotechnology company’s stock after buying an additional 264,052 shares during the quarter. Meritage Portfolio […]
State of Michigan Retirement System grew its holdings in shares of Exelixis, Inc. (NASDAQ:EXEL – Get Rating) by 1.2% in the fourth quarter, HoldingsChannel reports. The fund owned 82,116 shares of the biotechnology company’s stock after buying an additional 1,000 shares during the period. State of Michigan Retirement System’s holdings in Exelixis were worth $1,317,000 […]
StockNews.com downgraded shares of Exelixis (NASDAQ:EXEL – Get Rating) from a buy rating to a hold rating in a research report report published on Thursday morning. Other equities analysts have also recently issued reports about the company. Truist Financial reduced their target price on Exelixis from $35.00 to $32.00 in a research note on Friday, […]
Exelixis (NASDAQ:EXEL – Get Rating) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued on Thursday. EXEL has been the topic of several other research reports. EF Hutton Acquisition Co. I reissued a “buy” rating and set a $24.00 target price on shares of […]
20.01.2023 - Exelixis, Inc. (Nasdaq: EXEL) today announced that in the lawsuit Exelixis, Inc. (Exelixis) v. MSN Laboratories Private Limited et al. (MSN), Action No. 19-2017 (Consolidated), the U.S. District Court for the District of Delaware ruled in Exelixis’ . Seite 1
Exelixis, Inc. (NASDAQ:EXEL – Get Rating) has received an average recommendation of “Buy” from the eleven brokerages that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, one has given a hold rating, six have issued a buy rating and one has issued a strong buy […]
Exelixis, Inc. (NASDAQ:EXEL – Get Rating) EVP Jeffrey Hessekiel sold 4,717 shares of the business’s stock in a transaction dated Monday, March 28th. The stock was sold at an average price of $22.00, for a total transaction of $103,774.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is […]
Mackenzie Financial Corp Sells 71,715 Shares of Exelixis, Inc. (NASDAQ:EXEL) etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.